Tascilar, M.

ifosfamide cancer patient sarcoma sunitinib study treatment tissue medicine combination oncol alternative alternative medicine tissue sarcomas doxorubicin cancer patients therapy infusion schedule phase toxicity tissue sarcoma grade health agent cam use effect result metabolism trial activity neutropenia adult factor response product interaction research alternative medicine use concentration tumor group information metastatic metabolite breast 3 days response rates chemotherapy downloaded cycle inhibitor pharmacokinetic 3- day administration phase ii study 5- day schedule internet breast cancer quality 3- day schedule oncologist randomized cannabi women center high-dose ifosfamide figure antitumor survey web sites antitumor activity response rate oncology tascilar verweij event bone sarcoma group survival ifosfamide metabolism